Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/23/19 → 8/23/22 |
Funding
- Medpace Clinical Research LLC (Prot# 18-0108 // Prot# 18-0108)
- NGM Biopharmaceuticals, Inc. (Prot# 18-0108 // Prot# 18-0108)
Prot#18-0108: A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Two Doses of NGM282 Administered for 24 Weeks for the Treatment of Histologically Confirmed Nonalcoholic Steat
- Rinella, Mary Eugenia (PD/PI)
Project: Research project